Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis
Clinical and Experimental Nephrology · 2024
DOI: 10.1007/s10157-024-02498-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2024. Verfasst von Xuerui Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medi…. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Galectin 3, Cardiovascular Diseases, Heart Disease Risk Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Cardiovascular disease (CVD) represents the primary cause of mortality in patients afflicted with end-stage renal disease and undergoing peritoneal dialysis (PD) treatment. Galectin-3 (Gal-3), a molecule known to exhibit a correlation with CVD mortality garners considerable interest. The objective of this study was to explore the potential association between serum Gal-3 levels and other CVD risk factors among PD patients.
Methods
In this cross-sectional study, a total of 114 PD patients with a minimum of 3 months of PD treatment were enrolled. Serum Gal-3 levels were quantified using an enzyme-linked immunosorbent assay. The data of patients with Gal-3 levels higher and lower than 26.744 pg/ml were compared using Mann–Whitney U tests or t tests. Pearson’s correlation or Spearman’s correlation analysis and multivariate regression were used to assess the associations between the known risk factors for CVD and Gal-3.
Results
In comparison to the inter-group baseline data, the low Gal-3 group exhibited a higher glomerular filtration rate (GFR). Gal-3 levels correlate positively with PD duration, B-type natriuretic peptide (BNP), growth differentiation factor 15 (GDF-15), interventricular septal thickness in diastolic (IVST), and left ventricular mass index (LVMI). Conversely, Gal-3 exhibited a negative correlation with albumin levels. Multivariate linear regression analysis demonstrated a positive correlation between Gal-3 levels and BNP, GDF-15, PD duration, IVST and LVMI. Gal-3 levels were negatively correlated with albumin levels.
Conclusions
Gal-3 was strongly associated with BNP, GDF-15, IVST and LVMI in patients undergoing PD treatment. Prospective studies should be carried out to determine whether Gal-3 can be a promising biomarker in predicting increased risk of adverse cardiovascular events in PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, 1 Fuhua Road, Futian District, Shenzhen, 518033, Guangdong, Chin…
Zitieren
APA
Yang, X., Yang, J., Zeng, Y., Peng, L., Liu, X., Mo, J., Wang, T., Yao, Y., Zheng, Y., & Song, G. (2024). Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02498-3
Vancouver
Yang X, Yang J, Zeng Y, Peng L, Liu X, Mo J, et al. Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis. Clinical and Experimental Nephrology. 2024. doi:10.1007/s10157-024-02498-3
BibTeX
@article{Yang2024,
author = {Yang, Xuerui and Yang, Jun and Zeng, Youjia and Peng, Ling and Liu, Xingzheng and Mo, Jinying and Wang, Taifen and Yao, Yutong and Zheng, Yihou and Song, Gaofeng},
title = {Circulating galectin-3 level association with cardiovascular risk factors during peritoneal dialysis},
journal = {Clinical and Experimental Nephrology},
year = {2024},
doi = {10.1007/s10157-024-02498-3}
}
EUVIMED